SCHEMBL4491632

SCHEMBL4491632

Cc1c(CC(C)(C)C=O)sc2ccc(F)cc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CMA1 P23946 6/20 0.37
CYP17A1 P05093 1/20 0.36
MAPT P10636 3/20 0.34
TBXAS1 P24557 1/20 0.34
CRHR1 P34998 2/20 0.33
DHODH Q02127 1/20 0.33
PFKFB4 Q16877 1/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
TSHR P16473 1/20 0.31
MAPK1 P28482 1/20 0.31
BLM P54132 1/20 0.31
KMT2A Q03164 1/20 0.31
ATM Q13315 1/20 0.31
HIF1A Q16665 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4187011 0.81 L3MBTL1 (0.42) MAPTMEN1ALDH1A1CYP1A2TSHR
SCHEMBL12810668 0.76 CRHR1 (0.40) CMA1CYP17A1MAPTTBXAS1CRHR1
SCHEMBL1251629 0.72 MPO (0.40) CMA1CYP17A1MAPTCRHR1KMT2A
SCHEMBL1251627 0.72 CMA1 (0.38) CMA1CYP17A1MAPTCRHR1PFKFB4
SCHEMBL1251780 0.71 CYP17A1 (0.49) CMA1CYP17A1CRHR1PFKFB4ALDH1A1
SCHEMBL5331340 0.70 MTNR1A (0.38) CMA1CYP17A1MAPTTBXAS1CRHR1
SCHEMBL10033650 0.69 CYP17A1 (0.39) CMA1CYP17A1CRHR1DHODHPFKFB4
SCHEMBL2614663 0.68 CYP17A1 (0.42) CMA1CYP17A1CRHR1PFKFB4
SCHEMBL4774640 0.68 MTNR1A (0.38) CMA1CYP17A1MAPTTBXAS1MTNR1A
SCHEMBL4342850 0.67 CMA1 (0.41) CMA1CYP17A1TBXAS1MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664011-A4 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2009-02-25 EP disclosed
EP-1664011-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION Merck & Co., Inc. (US) 2006-06-07 EP disclosed
WO-2005020917-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO., INC. (US) 2005-03-10 WO disclosed